ECT2 and breast cancer: Kaplan-Meier survival analysis from GEO datasets indicates that elevated ECT2 expression predicts poor overall survival (OS), relapse free survival (RFS), distant metastasis free survival (DMFS), and post progression survival (PPS) in patients suffered from breast cancer (Figure S1D).